A Randomized, Double Blind, Placebo Controlled, Flexible Dose, Multicentre Study of Levitra [Vardenafil, BAY38-9456] in a Broad Population of Men With Erectile Dysfunction and Previously Untreated With PDE5 Inhibitors

Trial Profile

A Randomized, Double Blind, Placebo Controlled, Flexible Dose, Multicentre Study of Levitra [Vardenafil, BAY38-9456] in a Broad Population of Men With Erectile Dysfunction and Previously Untreated With PDE5 Inhibitors

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jan 2015

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms FINDER
  • Sponsors Bayer
  • Most Recent Events

    • 01 Aug 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004035).
    • 18 Nov 2009 Additional trial location (Spain) identified as reported by ClinicalTrials.gov.
    • 16 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top